MiMedx Group Inc (MDXG)
NASDAQ: MDXGHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
MDXG stock chart
Technical analysisKey statistics
All statistics- Market cap
- $672.76M
- P/E (TTM)
- 115.25
- Forward P/E
- 23.05
- EPS (TTM)
- $0.04
- Dividend yield
- None
- 52-week range
- 3.03 – 7.97
- Day range
- 4.57 – 4.68
- Volume / Avg
- 821.14K / 1.23M
- Beta
- —
- Shares outstanding
- 145.93M
- Next earnings
- Nov 4, 2026
52-week range
MDXG stock today
On Oct 7, MDXG ended the session at $4.61, shedding $0.01 (0.22%), versus the S&P 500's 0.22% decline. At this level, MDXG sits in the middle of its 52-week range of $3.03 to $7.97: 42.2% below the high, set on Nov 5, 2025 and 52.1% above the low. MDXG is down 31.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 36.5%.
MiMedx Group trades at 115.3x its trailing twelve-month earnings per share of $0.04. Its forward P/E of 23.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. MiMedx Group's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About MiMedx Group
Company profileMiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Joseph H. Capper
- Headquarters
- Marietta, GA
- Employees
- 808
- Website
- mimedx.com
Analyst forecast
ForecastConsensus (5 analysts)
none
Avg. price target
$7.40+60.52%
- Strong buy 1
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 4, 2026
MiMedx Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ANGOAngioDynamics Inc. | 14.19 | -1.59% | $596.75M | vs MDXG |
| KIDSOrthoPediatrics Corp. | 22.48 | -1.01% | $586.95M | vs MDXG |
| SSIISS Innovations International Inc. | 2.74 | -0.72% | $548.00M | vs MDXG |
| SGPSpyGlass Pharma Inc. | 23.90 | -3.55% | $799.41M | vs MDXG |
| DCTHDelcath Systems Inc. | 15.38 | -0.19% | $533.67M | vs MDXG |
| TCMDTactile Systems Technology Inc. | 22.02 | -0.77% | $498.80M | vs MDXG |
| SIBNSI-BONE Inc. | 19.10 | -2.30% | $856.03M | vs MDXG |
| SENSSenseonics Holdings Inc. | 9.16 | -8.03% | $484.33M | vs MDXG |
Indexes, lists and sector
MiMedx Group stock FAQ
What is MiMedx Group's stock price today?
MDXG last traded at $4.61 as of Oct 7, 4:00 PM EDT, down 0.22% on the day. Prices are delayed at least 15 minutes.
Does MiMedx Group pay a dividend?
No. MiMedx Group does not currently pay a regular cash dividend.
When is MiMedx Group's next earnings date?
MiMedx Group is expected to report earnings on Wednesday, November 4, 2026.
What is MDXG's P/E ratio?
MDXG trades at a trailing P/E ratio of 115.25 and a forward P/E of 23.05.
Who is MiMedx Group's CEO?
Mr. Joseph H. Capper is the chief executive officer of MiMedx Group Inc, which has about 808 employees.
Has MDXG ever split its stock?
Yes. The most recent MDXG stock split was a 3235-for-10000 split on Apr 2, 2008.
What is the MDXG 52-week high?
The 52-week high for MDXG is $7.97 and the 52-week low is $3.03. The stock is currently 42.2% below its high.